查詢結果分析
相關文獻
- Clinicopathological Differences between Mucinous Adenocarcinoma and Signet-Ring Cell Carcinoma in the Colorectum
- Colorectal Mucinous Carcinoma
- 大腸直腸癌篩檢簡介
- Irinotecan (Campto[feb9])--治療大腸直腸癌的新藥
- 大腸直腸癌的流行病學特徵及可能之成因
- 大腸直腸癌症病患生活品質及其相關因素之探討
- Colonoscopic Surveillance in Asymptomatic Persons with Family History of Colorectal Cancer
- Laparoscopic Colectomy is Superior to Laparotomy for Reduction of Disability in Patients with Colorectal Adenoma
- 大腸直腸癌術後肺臟轉移之手術治療
- 大腸直腸癌化學治療之近況
頁籤選單縮合
題 名 | Clinicopathological Differences between Mucinous Adenocarcinoma and Signet-Ring Cell Carcinoma in the Colorectum=大腸直腸黏液性腺癌和戒環細胞癌的臨床病理表現之差異 |
---|---|
作 者 | 林宏鑫; 林春吉; 藍苑慈; 王煥昇; 楊純豪; 姜正愷; 陳維熊; 林資琛; 林楨國; 張世慶; | 書刊名 | 中華民國大腸直腸外科醫學會雜誌 |
卷 期 | 23:4 2012.12[民101.12] |
頁 次 | 頁151-159 |
分類號 | 416.245 |
關鍵詞 | 大腸直腸; 戒環細胞癌; 黏液性腺癌; Colorectum; Signet-ring cell carcinoma; Mucinous adenocarcinoma; |
語 文 | 英文(English) |
中文摘要 | 目的 本研究的目的是評估大腸直腸戒環細胞癌和黏液性腺癌的臨床病理表現之間的差異。方法 從2000年1月至2007年12月,共19位大腸直腸戒環細胞癌和192位黏液性腺癌病人,針對年齡的差異,腫瘤部位,病理分期,術前腫瘤胚胎抗原指標,微衛星不穩定性,和五年整體存活率等,做了完整的病歷分析。結果 大腸直腸戒環細胞癌患者的平均年齡為60.4歲,MA 患者的平均年齡為65.6歲(p=0.001)。比起其他大腸腺癌病人(25%),我們注意到黏液性腺癌和戒環細胞癌患者右結腸分布的比例較高(35.4% 和36.8%)。此外,病人性別、術前腫瘤胚胎抗原指數偏高、微衛星不穩定性高表現的族群、和兩個亞型之間的腫瘤復發率無顯著差異。相對於黏液性腺癌患者(III/IV 期,64.1%),戒環細胞癌病患大多為較晚的腫瘤分期(III/IV 期,100.0%;p < 0.001)。戒環細胞癌患者5年存活率比黏液性腺癌患者差(29.5% 和57.8%;p < 0.001)。戒環細胞癌病人(17.6%)與黏液性腺癌(51.1%)相比有顯著較差的癌症特異性生存率(p<0.001)。結論 大腸直腸戒環細胞癌患者比黏液性腺癌患者有較晚的腫瘤期別和預後較差的結果。大腸直腸戒環細胞癌和黏液性腺癌之間的微衛星不穩定性分析沒有顯著性差異。 |
英文摘要 | Purpose. This study aimed to evaluate the clinicopathological differences between signet-ring cell carcinoma and mucinous adenocarcinoma of the colon and rectum.Methods. We prospectively reviewed the medical records between January 2000 and December 2007, and identified 19 patients with signet-ring cell carcinoma and 192 patients with mucinous adenocarcinoma. We examined the differences in age, tumor location, pathologic stage, pre-operative carcinoembryonic antigen level, microsatellite instability, and 5-year overall survival between each subtype.Results. The patients with signet-ring-cell carcinoma (mean age, 60.4 years) were slightly younger than patients with mucinous adenocarcinoma (mean age, 65.6 years; p=0.001). In addition, the incidence of mucinous adenocarcinoma and signet-ring cell carcinoma was higher in right-sided colon cancer (35.4% and 36.8%) than in other subtypes of colorectal cancer (25%). Further, no significant difference was observed in gender, preoperative carcinoembryonic antigen level, high probability of microsatellite instability, and tumor recurrence rate between the 2 subtypes. Signet-ring cell carcinoma was more likely to present at the later stages (stage III/IV, 100.0%) than mucinous adenocarcinoma (stage III/IV, 64.1%; p<0.001). The 5-year overall survival rates of patients with signet-ring cell carcinoma were poorer than those of patients with mucinous adenocarcinoma (29.5% vs. 57.8%; p<0.001). Patients with signet-ring cell carcinoma (17.6%) had significantly poorer cancer-specific survival than those with mucinous adenocarcinoma (51.1%; p<0.001).Conclusion. Colorectal signet-ring cell carcinoma patients had advanced disease and poorer outcome than mucinous adenocarcinoma patients. No significant difference was observed in microsatellite instability analyses between signet-ring cell carcinoma and mucinous adenocarcinoma. |
本系統中英文摘要資訊取自各篇刊載內容。